Buchumschlag

Small Molecule Kinase Inhibitors with In Vitro β‐Hematin Formation and Plasmodium falciparum Protein Kinase G Inhibitory Activity Identified Using Machine Learning

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Jessica L. Thibaud, Nicolaas Salomane, Sarah Harries, Kathryn J. Wicht, Lauren B. Coulson, David Kuter, Kelly Chibale, Katherine A. de Villiers
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2026
Schlagworte:	ChemMedChem
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Exploration of Antiplasmodium Chemical Space Identifies New Inhibitors of β ‐Hematin Formation from Areas of Enrichment
von: Jessica L. Thibaud, et al.
Veröffentlicht: (2026)

Recent Advances of Quinoline‐Based Small Molecules as Kinase Inhibitors (2020–2024)
von: Sara Sultan, et al.
Veröffentlicht: (2025)

Binding‐Site Switch for Protein Kinase CK2 Inhibitors
von: Dylan Grenier, et al.
Veröffentlicht: (2025)

Structural Analysis of the Macrocyclic Inhibitor BI‐4020 Binding to EGFR Kinase
von: Tyler S. Beyett, et al.
Veröffentlicht: (2024)

Emerging Trends in Quinoxaline‐Based Analogs as Protein Kinase Inhibitors: Structural Developments and SAR Insights
von: Shivani, et al.
Veröffentlicht: (2024)

Cyclin‐Dependent Kinase 11: Cellular Functions and Potential Therapeutic Applications
von: Janhabee Shrestha, et al.
Veröffentlicht: (2025)

Marine‐Inspired Spirooxindole PIM‐1 Kinase Inhibitors Endowed with Concomitant TRKA/CDK2 Inhibition for Multifaceted Non‐Small Cell Lung Cancer Apoptotic Induction
von: Refaah M. Al‐Jassas, et al.
Veröffentlicht: (2025)

Developing Dynamic Structure‐Based Pharmacophore and ML‐Trained QSAR Models for the Discovery of Novel Resistance‐Free RET Tyrosine Kinase Inhibitors Through Extensive MD Trajectories and NRI Analysis
von: Ehsan Sayyah, et al.
Veröffentlicht: (2024)

Synthesis and In Vitro Activity of Hypofuran B and Analogs Against Plasmodium Falciparum and Trypanosoma Cruzi
von: Cristiane Aparecida Franco, et al.
Veröffentlicht: (2025)

Targeting Plasmodium falciparum Single‐Stranded DNA‐Binding Protein: Discovery of New Scaffold Compounds Effective against Drug‐Sensitive and Artemisinin‐Resistant Strains
von: Biswajit Naik, et al.
Veröffentlicht: (2025)

C1′‐Branched Acyclic Nucleoside Phosphonates as Inhibitors of Plasmodium Falciparum 6‐Oxopurine Phosphoribosyltransferase
von: Jan Frydrych, et al.
Veröffentlicht: (2025)

Decoding Class III Phosphatidylinositol 3‐Kinase (PtdIns3K) Regulation: Mechanistic Insights and Therapeutic Opportunities
von: Qiao Liu, et al.
Veröffentlicht: (2026)

Small‐Molecule KRAS Inhibitors by Tyrosine Covalent Bond Formation
von: Alexander D. Landgraf, et al.
Veröffentlicht: (2025)

Balinatunfib: A Clinical Oral Small Molecule TNFα Inhibitor
von: Alexander Dömling, et al.
Veröffentlicht: (2025)

Targeting Inflammatory and Oncogenic Pathways: Cyclooxygenase‐2, Epidermal Growth Factor Receptor, and p38 Mitogen‐Activated Protein Kinase Inhibition by Pyrazolone Derivatives
von: Sevde Nur Biltekin Kaleli, et al.
Veröffentlicht: (2026)

Development of a Partial Proteolysis Targeting Chimera Library Based on Achiral Cereblon E3 Ligase Ligands and its Application for Bruton's Tyrosine Kinase Degraders
von: Chelsi M. Almodóvar‐Rivera, et al.
Veröffentlicht: (2025)

Investigating the C2 Modulation of the Imidazo[1,2‐a]pyrazine‐Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition
von: Lhana Tisseur, et al.
Veröffentlicht: (2025)

Research Progress and Clinical Translation Challenges of Small‐Molecule Inhibitors Targeting PD‐L1
von: Liang Qian, et al.
Veröffentlicht: (2026)

Selenocyanate‐Containing Molecules as Trypanosoma cruzi Inhibitors: Impact of Regioisomerism, Conformational Restriction, and Second‐Ring Substitution
von: Hugo S. Steingrüber, et al.
Veröffentlicht: (2025)

Small‐Molecule Allosteric Inhibitors of Human Aspartate Transcarbamoylase Suppress Proliferation of Bone Osteosarcoma Epithelial Cells
von: Chao Wang, et al.
Veröffentlicht: (2024)

Preparation of Dearomatized p‐Coumaric Acid Derivatives as DNA Damage Response Inhibitors with Potent In Vitro Antitumor Effect
von: Laura Fási, et al.
Veröffentlicht: (2024)

Structure‐Based Virtual Screening and Biological Characterization of Novel BACE‐1 and Amyloid‐β Aggregation Inhibitors
von: Ankita Sharma, et al.
Veröffentlicht: (2024)

Small‐Molecule Inhibitors Targeting PD‐1/PD‐L1 in Colorectal Cancer: Mechanisms, Challenges, and Clinical Prospects
von: Jianwei Wang, et al.
Veröffentlicht: (2025)

Structure‐Based Virtual Screening Identifies TREM2‐Targeted Small Molecules that Enhance Microglial Phagocytosis
von: Sungwoo Cho, et al.
Veröffentlicht: (2026)

Virtual and in Vitro Screening Employing a Repurposing Approach Reveal 13‐cis‐Retinoic Acid is a PTP1B Inhibitor
von: Reyna Del Carmen Navarrete‐Mondragón, et al.
Veröffentlicht: (2024)

A Novel Triose Phosphate Isomerase Inhibitor With Dual Trypanosomicidal Activity was Identified Using Artificial Intelligence‐Based Virtual Screening
von: Elena Aguilera, et al.
Veröffentlicht: (2026)

Design, Synthesis, and Biological Evaluation of Small‐Molecule PD‐1/PD‐L1 Inhibitors Bearing a Rigid Benz[d]oxazole Skeleton
von: Bo Wei, et al.
Veröffentlicht: (2026)

4‐Aza Cyclopentenone Prostaglandin Analogues: Synthesis and NF‐κB Inhibitory Activities
von: William Doherty, et al.
Veröffentlicht: (2024)

Cytotoxic, Antibacterial, and in Silico Pks13 Inhibitory Properties of Indole‐Coupled Dihydrobenzo[c]phenanthridines
von: Reyna Martha Gallegos‐Alvarado, et al.
Veröffentlicht: (2025)

Discovery of Potent Isoindolinone Inhibitors that Target an Active Conformation of PARP1 Using DNA‐Encoded Libraries
von: Kelly A. McCarthy, et al.
Veröffentlicht: (2024)

Design, Synthesis, and Xanthine Oxidase Inhibitory Activity of 4‐(5‐Aminosubstituted‐4‐cyanooxazol‐2‐yl)benzoic Acids
von: Oleksandr Kobzar, et al.
Veröffentlicht: (2024)

Small‐Molecule Fluorescent Probes for Butyrylcholinesterase
von: Zibo Lin, et al.
Veröffentlicht: (2025)

Front Cover: Cholinesterase Inhibitory Activity and Molecular Docking Studies of Isocryptolepine‐Triazole Adducts (ChemMedChem 24/2024)
von: Jumreang Tummatorn, et al.
Veröffentlicht: (2024)

Structure‐ and Ligand‐Based Discovery of Novel 3‐Chymotrypsin‐Like Protease Nonpeptidomimetic Hits
von: Sabrina Silva‐Mendonça, et al.
Veröffentlicht: (2026)

Front Cover: Structure‐ and Ligand‐Based Discovery of Novel 3‐Chymotrypsin‐Like Protease Nonpeptidomimetic Hits (ChemMedChem 7/2026)
von: Sabrina Silva‐Mendonça, et al.
Veröffentlicht: (2026)

APH Inhibitors that Reverse Aminoglycoside Resistance in Enterococcus casseliflavus
von: Elise Kaplan, et al.
Veröffentlicht: (2025)

The Role of Protein Disulfide Isomerase Inhibitors in Cancer Therapy
von: Qiuying Nie, et al.
Veröffentlicht: (2024)

Challenges for the Discovery of Non‐Covalent WRN Helicase Inhibitors
von: Alisa Heuser, et al.
Veröffentlicht: (2024)

Improving Affinity while Reducing Kidney Uptake of CXCR4‐Targeting Radioligands Derived from the Endogenous Antagonist EPI‐X4
von: Raghuvir H. Gaonkar, et al.
Veröffentlicht: (2025)

Cover Feature: Improving Affinity while Reducing Kidney Uptake of CXCR4‐Targeting Radioligands Derived from the Endogenous Antagonist EPI‐X4 (ChemMedChem 6/2025)
von: Raghuvir H. Gaonkar, et al.
Veröffentlicht: (2025)